Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 21;14(1):e12328.
doi: 10.1002/dad2.12328. eCollection 2022.

Reply to "Pathway for ascertaining the role of uric acid in neurodegenerative diseases," Roman Youssef

Mats Dehlin  1 , Tahzeeb Fatima  1   2 , Lennart T H Jacobsson  1 , Silke Kern  3 , Anna Zettergren  3 , Kaj Blennow  3   4 , Henrik Zetterberg  3   4   5   6 , Lena Johansson  3 , Ingmar Skoog  3
Affiliations

Reply to "Pathway for ascertaining the role of uric acid in neurodegenerative diseases," Roman Youssef

Mats Dehlin et al. Alzheimers Dement (Amst). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Tahzeeb Fatima, Lennart T.H. Jacobsson, Anna Zettergren, Mats Dehlin, and Ingmar Skoog declare no conflicts of interest. Silke Kern has served as a consultant, on advisory boards for Geras Solutions, unrelated to the results presented in this paper. Kaj Blennow has served as a consultant, on advisory boards, or on data‐monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu, Julius Clinical, Lilly, MagQu, Novartis, Roche Diagnostics, and Siemens Healthineers, and is a cofounder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, all unrelated to the results presented in this paper. Henrik Zetterberg has served on scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed, SiemensHealthineers, Pinteon Therapeutics, Nervgen, and CogRx; has given lectures in symposia sponsored by Fujirebio, Alzecure, and Biogen; and is a co‐founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, all unrelated to the results presented in this paper.

Similar articles

See all similar articles

References

    1. Deckers K, Camerino I, van Boxtel MP, et al. Dementia risk in renal dysfunction: a systematic review and meta‐analysis of prospective studies. Neurology. 2017;88:198‐208. - PMC - PubMed
    1. García‐Ptacek S, Faxén‐Irving G, Čermáková P, Eriksdotter M, Religa D. Body mass index in dementia. Eur J Clin Nutr. 2014;68:1204‐1209. - PubMed
    1. Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF. Uric acid as a CNS antioxidant. J Alzheimers Dis. 2010;19:1331‐1336. - PMC - PubMed
    1. Constantinescu R, Andreasson U, Holmberg B, Zetterberg H. Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies. Acta Neurologica Scandinavica. 2013;127:e8‐e12. - PubMed